Acorda Therapeutics Inc

NASDAQ:ACOR  
2.82
-0.27 (-8.74%)
Earnings Announcements

Acorda Therapeutics Posts Q3 Loss Per Share Of $2.43

Published: 11/09/2021 21:36 GMT
Acorda Therapeutics Inc (ACOR) - Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team.
Q3 Non-GAAP Loss per Share $1.43.
Q3 GAAP Loss per Share $2.43.
Revenue is expected to be $30.57 Million
Adjusted EPS is expected to be -$1.56

Next Quarter Revenue Guidance is expected to be $31.01 Million
Next Quarter EPS Guidance is expected to be -$1.11

More details on our Analysts Page.